A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
- PMID: 38564982
- DOI: 10.1016/j.ijnurstu.2024.104705
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
Abstract
The UK Medical Research Council's widely used guidance for developing and evaluating complex interventions has been replaced by a new framework, commissioned jointly by the Medical Research Council and the National Institute for Health Research, which takes account of recent developments in theory and methods and the need to maximise the efficiency, use, and impact of research.
Copyright © 2024 BMJ Publishing Group Ltd. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: support from the NIHR, MRC, and the funders listed above for the submitted work; KS has project grant funding from the Scottish GovernmentChief Scientist Office; SAS is a former member of the NIHR Health Technology Assessment Clinical Evaluation and Trials Programme Panel (November 2016–November 2020) and member of the Chief Scientist Office Health HIPS Committee (since 2018) and NIHR Policy Research Programme (since November 2019), and has project grant funding from the Economic and Social Research Council, MRC, and NIHR; LMo is a former member of the MRC-NIHR Methodology Research Programme Panel (2015–19) and MRC Population Health Sciences Group (2015–20); JB is a member of the NIHR Public Health Research Funding Committee (since May 2019), and a core member (since 2016) and vice chairperson (since 2018) of a public health advisory committee of the National Institute for Health and Care Excellence; JMB is a former member of the NIHR Clinical Trials Unit Standing Advisory Committee (2015–19); DPF is a former member of the NIHR Public Health Research programme research funding board (2015–2019), the MRC-NIHR Methodology Research Programme panel member (2014–2018), and is a panel member of the Research Excellence Framework 2021, subpanel 2 (public health, health services, and primary care; November 2020–February 2022), and has grant funding from the European Commission, NIHR, MRC, Natural Environment Research Council, Prevent Breast Cancer, Breast Cancer Now, Greater Sport, Manchester University NHS Foundation Trust, Christie Hospital NHS Trust, and BXS GP; EM is a member of the NIHR Public Health Research funding board; MP has grant funding from the MRC, UK Prevention Research Partnership, and NIHR; JR-M is programme director and chairperson of the NIHR's Health Services Delivery Research Programme (since 2014) and member of the NIHR Strategy Board (since 2014); MW received a salary as director of the NIHR PHR Programme (2014–20), has grant funding from NIHR, and is a former member of the MRC's Population Health Sciences Strategic Committee (July 2014 to June 2020). There are no other relationships or activities that could appear to have influenced the submitted work.
Publication types
MeSH terms
Grants and funding
- MC_UU_00022/1/MRC_/Medical Research Council/United Kingdom
- MC_PC_13027/MRC_/Medical Research Council/United Kingdom
- MC_UU_12017/14/MRC_/Medical Research Council/United Kingdom
- SPHSU13/CSO_/Chief Scientist Office/United Kingdom
- SPHSU14/CSO_/Chief Scientist Office/United Kingdom
- MR/K025643/1/MRC_/Medical Research Council/United Kingdom
- MC_UU_12017/11/MRC_/Medical Research Council/United Kingdom
- MC_UU_00006/7/MRC_/Medical Research Council/United Kingdom
- MC_UU_00022/3/MRC_/Medical Research Council/United Kingdom
- MC_UU_00022/2/MRC_/Medical Research Council/United Kingdom
- MC_UU_12015/6/MRC_/Medical Research Council/United Kingdom
- SPHSU16/CSO_/Chief Scientist Office/United Kingdom
- SPHSU11/CSO_/Chief Scientist Office/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
